Dariusz Belowski

480 total citations
22 papers, 403 citations indexed

About

Dariusz Belowski is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Dariusz Belowski has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Dariusz Belowski's work include Lipoproteins and Cardiovascular Health (7 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Dariusz Belowski is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Dariusz Belowski collaborates with scholars based in Poland and United Kingdom. Dariusz Belowski's co-authors include Bogusław Okopień, Zbigniew S. Herman, Andrzej Madej, Jan Kowalski, Robert Krysiak, Krzysztof Łabuzek, Z Kalina, Grzegorz Machnik, Marcin Basiak and Łukasz Bułdak and has published in prestigious journals such as Atherosclerosis, European Journal of Clinical Pharmacology and Microvascular Research.

In The Last Decade

Dariusz Belowski

22 papers receiving 385 citations

Peers

Dariusz Belowski

SURGE

EDM

EPIDE

IMMUN

Abass M. Conteh United States

Marcin Basiak Poland

Tatsuto Notsu Japan

Aya Shiraki Japan

Jorge Plutzky United States

Chikage Sato Japan

Aleksandra Bołdys Poland

Kiyohiko Negishi Japan

Ji Eun Lee South Korea

Motofumi Sasaki Japan

Abass M. Conteh United States

Dariusz Belowski

175 ×1.3

SURGE

158 ×1.3

121 ×1.1

EDM

93 ×0.9

EPIDE

38 ×0.5

IMMUN

Citations per year, relative to Dariusz Belowski Dariusz Belowski (= 1×) peers Abass M. Conteh

Countries citing papers authored by Dariusz Belowski

Since Specialization

Citations

This map shows the geographic impact of Dariusz Belowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dariusz Belowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dariusz Belowski more than expected).

Fields of papers citing papers by Dariusz Belowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dariusz Belowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dariusz Belowski. The network helps show where Dariusz Belowski may publish in the future.

Co-authorship network of co-authors of Dariusz Belowski

This figure shows the co-authorship network connecting the top 25 collaborators of Dariusz Belowski. A scholar is included among the top collaborators of Dariusz Belowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dariusz Belowski. Dariusz Belowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Łabuzek, Krzysztof, et al.. (2015). Koncepcja niestabilnej blaszki miażdżycowej i farmakologiczne strategie terapeutyczne. 17. 49–68. 2 indexed citations

Gabryel, Bożena, et al.. (2015). Superoxide dismutase 1 and glutathione peroxidase 1 are involved in the protective effect of sulodexide on vascular endothelial cells exposed to oxygen–glucose deprivation. Microvascular Research. 103. 26–35. 25 indexed citations

Bułdak, Łukasz, Grzegorz Machnik, Rafał Jakub Bułdak, et al.. (2015). Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner. Pharmacological Reports. 68(2). 329–337. 57 indexed citations

Okopień, Bogusław, Maciej Haberka, Andrzej Madej, et al.. (2007). Extralipid effects of micronized fenofibrate in dyslipidemic patients.. PubMed. 58(5). 729–35. 16 indexed citations

Belowski, Dariusz, Jan Kowalski, Andrzej Madej, & Zbigniew S. Herman. (2006). Influence of antidepressant drugs on macrophage cytotoxic activity in rats.. PubMed. 56(6). 837–42. 13 indexed citations

Okopień, Bogusław, Marcin Basiak, Andrzej Madej, et al.. (2006). [Markers of inflammatory process in stable and unstable coronary artery disease].. PubMed. 21(121). 69–72. 3 indexed citations

Okopień, Bogusław, Robert Krysiak, Andrzej Madej, et al.. (2006). Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia.. PubMed. 56(6). 781–7. 14 indexed citations

Okopień, Bogusław, et al.. (2005). Hypolipidemic Drugs Affect Monocyte IL-1β Gene Expression and Release in Patients with IIa and IIb Dyslipidemia. Journal of Cardiovascular Pharmacology. 45(2). 160–164. 18 indexed citations

Okopień, Bogusław, Robert Krysiak, Jan Kowalski, et al.. (2005). Monocyte Release of Tumor Necrosis Factor-α and Interleukin-1β in Primary Type IIa and IIb Dyslipidemic Patients Treated With Statins or Fibrates. Journal of Cardiovascular Pharmacology. 46(3). 377–386. 48 indexed citations

10.

Wysocki, J, et al.. (2004). Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. International Journal of Clinical Pharmacology and Therapeutics. 42(4). 212–217. 41 indexed citations

11.

Okopień, Bogusław, Robert Krysiak, Jan Kowalski, et al.. (2004). The effect of statins and fibrates on interferon-γ and interleukin-2 release in patients with primary type II dyslipidemia. Atherosclerosis. 176(2). 327–335. 51 indexed citations

12.

Kowalski, Jan, Bogusław Okopień, Andrzej Madej, et al.. (2003). Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia. International Journal of Clinical Pharmacology and Therapeutics. 41(6). 241–247. 31 indexed citations

13.

Kowalski, Jan, Dariusz Belowski, Bogusław Okopień, et al.. (2003). Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. European Journal of Clinical Pharmacology. 59(3). 189–193. 24 indexed citations

14.

Okopień, Bogusław, Joseph M. Kowalski, Dariusz Belowski, et al.. (2002). A new immunological marker of atherosclerotic injury of arterial wall.. PubMed. 109(3-4). 241–8. 8 indexed citations

15.

Krysiak, Robert, Bogusław Okopień, Dariusz Belowski, Andrzej Madej, & Zbigniew S. Herman. (2001). Recent insights into body weight control: From physiology to pathology. Journal of Peptide Science. 7(11). 571–578. 6 indexed citations

16.

Kowalski, Jan, et al.. (2000). Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages. Neuropeptides. 34(3-4). 187–192. 16 indexed citations

17.

Madej, Andrzej, et al.. (1998). Influence of neuroleptics on cytotoxic activity of macrophages in rats.. PubMed. 137(5). 135–9. 1 indexed citations

18.

Belowski, Dariusz, et al.. (1996). Bidirectional modulation of mouse natural killer cell and macrophage cytotoxic activities by enkephalins.. PubMed. 47(4). 327–31. 9 indexed citations

19.

Kowalski, Jan, et al.. (1996). Effects of thiorphan, bestatin and captopril on the Lewis lung carcinoma metastases in mice.. PubMed. 47(5). 423–7. 5 indexed citations

20.

Kowalski, Jennifer A., Dariusz Belowski, Andrzej Madej, & Zbigniew S. Herman. (1995). Antitumor activity of bestatin and thiorphan in mice.. PubMed. 43(5-6). 265–71. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact